Press Releases Home - Investor Relations - Press Releases Press Releases Year None202220212020201920182017201620152014 Date Title May 5, 2022 Corcept Therapeutics Announces First Quarter Financial Results And Provides Corporate Update April 28, 2022 Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call April 7, 2022 Corcept Therapeutics Announces Appointment of Three Senior Leaders April 4, 2022 Corcept Therapeutics Completes Enrollment in Phase 2 GRATITUDE Study of Miricorilant in Patients with Antipsychotic-Induced Weight Gain March 30, 2022 Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian Cancer March 1, 2022 Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022 February 15, 2022 Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate Update February 8, 2022 Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call Shareholder Tools Email Alerts Print Page RSS Feeds
Press Releases Year None202220212020201920182017201620152014 Date Title May 5, 2022 Corcept Therapeutics Announces First Quarter Financial Results And Provides Corporate Update April 28, 2022 Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call April 7, 2022 Corcept Therapeutics Announces Appointment of Three Senior Leaders April 4, 2022 Corcept Therapeutics Completes Enrollment in Phase 2 GRATITUDE Study of Miricorilant in Patients with Antipsychotic-Induced Weight Gain March 30, 2022 Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian Cancer March 1, 2022 Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022 February 15, 2022 Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate Update February 8, 2022 Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call